Posted 23 April, 2021
NeuroPace Inc IPO completed
IPO completed detected for ticker Nasdaq:NPCE in a 424B4 filed on 23 April, 2021.
This is our initial public offering of our common stock.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of NeuroPace Inc
Health Care/Life Sciences • Medical Equipment/Supplies
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.Market Cap
$365M
View Company Details
$365M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.